Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

The drug booster to the brain

Media & Press, News
Sometimes drugs need a bigger push to be more effective and reach their final destination:Expansion

Sometimes drugs need a bigger push to be more effective and reach their final destination: the brain. The three families of peptides (proteins) developed and patented by Gate2Brain fulfill this mission by acting as a shuttle or tractor for drugs to act on this organ and treat localized pathologies.

This development led by Meritxell Teixidó, CEO of the company, after several years of work, has been possible thanks to a team of researchers and professionals from the University of Barcelona, ​​IRB Barcelona and Hospital Sant Joan de Déu. The first application of this technology will be for the treatment of pediatric cancer, when it is located in the brain.

“We are currently in the preclinical phase and the first clinical trial with pediatric patients is scheduled for 2026, at the Sant Joan de Déu Hospital, a reference center for childhood diseases”, explains Teixidó. The company has recently drawn the attention from the EIC Accelerator program of the European Union, which has injected 2.5 million euros into it.

Source: Expansión Start Up

February 28, 2023/by noticias
Tags: Biotech, Expansión, pediatriccancer, research, Startup
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2023/02/Copia-de-Fashion-Quote-Instagram-feed-post-3.png 1080 1080 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2023-02-28 10:41:162025-02-19 09:36:02The drug booster to the brain
You might also like
BioSpain2021Gate2Brain attending BioSpain 2021
Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.Gate2Brain will be attending The Investment Readiness Series
Una tecnología para ayudar a tratar el cáncer infantilgate2brainA technology to help treat pediatric cancer
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.TransfiereGate2Brain in Transfiere – European Forum for Science, Technology & Innovation
Gate2Brain among the 5 Catalan startups that have obtained funding from EIC AcceleratorcanvaGate2Brain among the 5 Catalan startups that have obtained funding from EIC Accelerator
medicines beyond barriersG2BMedicines beyond barriers
Nadia Calviño, First Vice President of the Government and Minister of Economic Affairs visits Gate2BrainSJDNadia Calviño, First Vice President of the Government visits Gate2Brain
talento científicotalento cientificoFounding a company in times of pandemic

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
G2B at Transfiere 2023Gate2Brain at TransfiereG2BG2B at 4YFN 2023G2BGate2Brain at 4YFN-MWC23
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}